ArticleThe Journal of biological chemistry2018

A potent, proteolysis-resistant inhibitor of kallikrein-related peptidase 6 (KLK6) for cancer therapy, developed by combinatorial engineering.

Amiram Sananes et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.